found that intraperitoneal administration of 15 mg/kg MOTS-c three times a week starting at 23.5 months of age caused a trend toward increased lifespan that did not quite reach significance ( 65 ).
1
—
—
found that intraperitoneal administration of 15 mg/kg MOTS-c three times a week starting at 23.5 months of age caused a trend toward increased lifespan that did not quite reach significance ( 65 ).